Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PRDM1 anticorps

L’anticorps Souris Monoclonal anti-PRDM1 a été validé pour WB et IHC. Il convient pour détecter PRDM1 dans des échantillons de Humain. Il y a 5+ publications disponibles.
N° du produit ABIN2668849

Aperçu rapide pour PRDM1 anticorps (ABIN2668849)

Antigène

Voir toutes PRDM1 Anticorps
PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))

Reactivité

  • 55
  • 17
  • 11
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 34
  • 22
  • 3
  • 2
Souris

Clonalité

  • 39
  • 22
Monoclonal

Conjugué

  • 45
  • 6
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp PRDM1 est non-conjugé

Application

  • 50
  • 28
  • 13
  • 10
  • 8
  • 7
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Clone

ROS195
  • Purification

    Protein G Chromatography

    Immunogène

    This PRDM1 / BLIMP1 antibody was raised against full-length recombinant human PRDM1 / BLIMP1 protein.

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    1 μg/μL

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles and keep on ice when not in storage.

    Stock

    -20 °C

    Stockage commentaire

    Antibodies in solution can be stored at -20 °C for 2 years.

    Date de péremption

    6 months
  • Nie, Gomez, Landgraf, Garcia, Liu, Tan, Chadburn, Tuschl, Knowles, Tam: "MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." dans: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).

    Zhao, Liu, Zhang, Wang, Leboeuf, Zhang, Ma, Garcia, Song, Li, Shen, Chen, Janin, Chen: "PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor." dans: Blood, Vol. 111, Issue 7, pp. 3867-71, (2008) (PubMed).

    Liu, Leboeuf, Shi, Li, Wang, Shen, Garcia, Shen, Chen, Janin, Chen, Zhao: "Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma." dans: Blood, Vol. 110, Issue 1, pp. 339-44, (2007) (PubMed).

    Garcia, Roncador, García, Sánz, Maestre, Lucas, Montes-Moreno, Fernandez Victoria, Martinez-Torrecuadrara, Marafioti, Mason, Piris: "PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma." dans: Haematologica, Vol. 91, Issue 4, pp. 467-74, (2006) (PubMed).

    Valer Corellano: "[Malignant fibrous histiocytoma of soft tissues: early report of 10 cases]." dans: Medicina clínica, Vol. 97, Issue 7, pp. 279, (1991) (PubMed).

  • Antigène

    PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))

    Autre désignation

    PRDM1 / BLIMP1

    Poids moléculaire

    77 & 95 kDa

    ID gène

    639

    Pathways

    Regulation of Muscle Cell Differentiation
Vous êtes ici:
Chat with us!